Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | environmental violation | 2023 | MA-ENV | $11,615 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2003 | NJ-ENV | $28,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2001 | NJ-ENV | $6,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2011 | CT-ENV | $20,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $220,000,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | environmental violation | 2000 | EPA | $5,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | export control violation | 2004 | BIS | $16,200 |
Briston-Myers Squibb | Bristol-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
CAMBREX CHARLES CITY, INC | Cambrex | environmental violation | 2006 | EPA | $106,749 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2007 | OSHA | $6,375 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2018 | OSHA | $18,000 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
Celgene Corp. | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
Celgene Corporation | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
Celgene Corporation | Bristol-Myers Squibb | environmental violation | 2013 | EPA | $6,035 |
Cephalon | Teva Pharmaceutical Industries | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Cephalon Inc | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Cherokee Pharmaceuticals | Merck | railroad safety violation | 2021 | FRA | $5,000 |
CHEROKEE PHARMACEUTICALS LLC | Merck | benefit plan administrator violation | 2011 | EBSA | $10,001 |
CHIRON CORPORATION | Novartis | workplace safety or health violation | 2000 | OSHA | $90,140 |
Chiron Corporation Ltd | Novartis | economic sanction violation | 2004 | OFAC | $168,500 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Clovis Oncology Inc. | Clovis Oncology | investor protection violation | 2018 | SEC | $20,000,000 |
Cody Laboratories Inc | Lannett Co. | motor vehicle safety violation | 2018 | FMCSA | $8,510 |
COVIDIEN DBA MALLINCKRODT INC. | Mallinckrodt | workplace safety or health violation | 2010 | OSHA | $41,613 |
CSL Behring LLC | CSL Limited | environmental violation | 2015 | EPA | $62,780 |
CSL BEHRING LLC | CSL Limited | environmental violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
CSL Behring, LLC | CSL Limited | environmental violation | 2021 | EPA | $527,144 |
CSL Limited | CSL Limited | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
CSL PLASMA | CSL Limited | workplace safety or health violation | 2019 | OSHA | $15,422 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Cytrx Corporation | CytRx | investor protection violation | 2017 | SEC | $75,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Daiichi Sankyo | Daiichi Sankyo | employment discrimination | 2016 | private lawsuit-federal | $8,200,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | DOJ_CIVIL | $39,000,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | product safety violation | 2017 | private lawsuit-federal | $300,000,000 |
Daiichi Sankyo, Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | MULTI-AG | $39,000,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Depuy Orthopaedics Inc. | Johnson & Johnson | False Claims Act and related | 2007 | USAO | $84,700,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
DePuy Orthopaedics, Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
DEPUY SYNTHES | Johnson & Johnson | workplace safety or health violation | 2019 | OSHA | $5,000 |
DePuy Synthes | Johnson & Johnson | environmental violation | 2019 | EPA | $51,750 |
DEPUY SYNTHES PRODUCTS, INC. | Johnson & Johnson | workplace safety or health violation | 2022 | OSHA | $7,044 |
DEPUY SYNTHES PRODUCTS, LLC | Johnson & Johnson | workplace safety or health violation | 2018 | OSHA | $5,654 |
Depuy Synthes Sales, Inc. | Johnson & Johnson | wage and hour violation | 2020 | CA-LCO | $57,488 |
DePuy Synthes, Inc. | Johnson & Johnson | False Claims Act and related | 2023 | DOJ_CIVIL | $9,750,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey LP | Viatris | False Claims Act and related | 2007 | MT-AG | $198,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
Dey, Inc. | Viatris | fraud | 2004 | AR-AG | $600,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | NV-AG | $670,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Dey, Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |